Latest News
Morepen Laboratories Limited
- Morepen Laboratories wins Himachal Pradesh High Court relief in ₹118 crore GST refund case
- Morepen Labs hits new high on huge volume; stock up 191% in 4 months
- Morepen Laboratories Files First US ANDA for Sitagliptin
- Morepen Laboratories promotes Sanjay Suri to MD
- Morepen strengthens integrated CDMO capabilities with first US ANDA submission
- Morepen Laboratories shares jump 5% after first US ANDA filing for diabetes drug; zoom 267% in 6 months
- Morepen Labs Files First US ANDA for Sitagliptin Tablets in 25mg, 50mg, 100mg Strengths
- Morepen Labs Submits First U.S. ANDA For Sitagliptin Tablets
- Morepen files first US drug application, eyes generic diabetes market
- Morepen Laboratories Share Price Rises on First US ANDA Filing
- Morepen Laboratories files first US ANDA for Sitagliptin tablets
- Morepen Laboratories Submits First U.S. ANDA For Sitagliptin Tablets USP In Three Strengths
Headlines from the last 30 days, linking to the original publishers. See all market news →